Company / Net Income
BeOne Medicines Ltd. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$286.9M
FY2025
5-year range
-$2.0B / $286.9M
FY2021-FY2025
Trend
+144.5%
vs FY2024
Sector context
#29 of 216
Health Care
What the data says
BeOne Medicines Ltd.'s net income of $287M is higher than 87% of companies in the Health Care sector (FY2025). Net Income has increased for 3 consecutive years, from -$2.0B in FY2022 to $287M in FY2025.
Based on SEC 10-K filings.
$287M in FY2025. Top quartile in the Health Care sector.
Improved from -$882M to $287M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 216This company $286.9M Sector average $454.1M
▼
-36.8% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 144.5% year-over-year.
- Ranks #29 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $286.9M | +144.5% |
| FY2024 | -$644.8M | +26.9% |
| FY2023 | -$881.7M | +56.0% |
| FY2022 | -$2.0B | -37.5% |
| FY2021 | -$1.5B | +10.3% |
| FY2020 | -$1.6B | -71.3% |
| FY2019 | -$948.6M | -40.8% |
| FY2018 | -$673.8M | -623.7% |
| FY2017 | -$93.1M | +21.9% |
| FY2016 | -$119.2M | -108.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026